Login
← Go Back
Gufic Biosciences
GUFICBIO · Pharma > Pharmaceuticals & Drugs · Chairman: Jayesh P Choksi · MD: Jayesh P Choksi · Listing date: Oct. 20, 2004 · Employees: 1247 · Mumbai · http://gufic.com
Stock Price vs Company Growth
1d
2.3%
1w
14.3%
1m
11.1%
3m
14.8%
6m
11.7%
1y
15.1%
5y
11.9%
10y
23.0%
all
19.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 325 2.3%
268
329
Company Overview
Sales
897 Cr
Growth: 9.3%
Profit after Tax
50 Cr
Growth: -12.1%
Small Cap
3,264 Cr
P/E: 65.2x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 897
Growth 9.3%
EBITDA 14.5%
P/S 3.6x
Dividend 0.0%
P/E 65.2x
Book Value ₹ 1
PEG Ratio 7.0x
ROE 499.0%
P/B N/A
Shareholding Pattern
Institutions
Sbi Healthcare Opportunities Fund
2.61 %
Promoters
Mr. Jayesh P. Choksi
25.95 %
Zircon Teconica Private Limited (Formely Known As Zircon Finance & Leasing Private Limited)
21.17 %
Gufic Private Limited
10.51 %
Mr. Pranav J. Choksi
7.5 %
Others
Vipula Jayesh Choksi
10.35 %
Jagdish N Master
1.65 %
Iepf
0.21 %
Increase    Decrease    No change
Company Profile Detailed
The company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.Products of the companyPharmaceuticalHerbalAPI / Bulk DrugsPersonal careInternationalHistory and milestonePast InitiativesFirst Indian to produce Doxycycline Inj.First Indian company to make Liquid Oxytetracycline Inj.
Belongs to (8 Indices) view more
Investors (45)
icici.pr...
finco.ca...
sbi.acti...
Followers (8)
indrajee...
nihal
mrinmoy4